Drug Patents owned by Telix
1. List of Illuccix drug patents
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US11027031 | TELIX | Kit for radiolabelling |
Jul, 2035
(12 years from now) | |
Do you want to check out ILLUCCIX patents from before 2022?
Drugs and Companies using GALLIUM GA-68 GOZETOTIDE ingredient
Market Authorisation Date: 17 December, 2021
Treatment: Positron emission tomography (pet) of prostate-specific membrane antigen (psma) positive lesions in men with prostate cancer
Dosage: POWDER;INTRAVENOUS
More Information on Dosage
ILLUCCIX family patents
10
United States
6
Australia
6
European Union
3
Canada
2
New Zealand
2
China
2
Spain
2
Russia
2
Israel
2
Brazil
2
Mexico
2
Japan
1
Poland
1
Belgium
1
Portugal
1
South Africa
1
Denmark
1
Hungary
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic